Loading...

Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.


如何输入v2ray节点

July 31, 2023 - Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results July 7, 2023 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2023 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

如何输入v2ray节点

如何输入v2ray节点

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

如何输入v2ray节点

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR
免费的梯子加速  快连vpn续费  ,极光加速器  静静和马动画叫什么  手机怎样看国外网站  安卓浏览器浏览国外